Tuesday, 22 Jul 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • VIDEO
  • ScienceAlert
  • White
  • Watch
  • Trumps
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > The White House > President Donald J. Trump Announces Actions to Reduce Regulatory Barriers to Domestic Pharmaceutical Manufacturing – The White House
The White House

President Donald J. Trump Announces Actions to Reduce Regulatory Barriers to Domestic Pharmaceutical Manufacturing – The White House

Last updated: May 5, 2025 8:10 pm
Share
President Donald J. Trump Announces Actions to Reduce Regulatory Barriers to Domestic Pharmaceutical Manufacturing – The White House
SHARE

BOOSTING AMERICAN-PRODUCED PHARMACEUTICALS: Today, President Donald J. Trump enacted an Executive Order aimed at revitalizing the domestic production of prescription drugs, including the essential ingredients and materials required for their manufacture.

  • This Executive Order instructs the U.S. Food and Drug Administration (FDA) to expedite the approval process for domestic pharmaceutical manufacturing facilities by eliminating redundant and unnecessary regulatory hurdles, simplifying reviews, and collaborating with local manufacturers to provide proactive support before these facilities become operational.
    • The Order also mandates the FDA to increase fees and inspections for foreign manufacturing plants.

    • Further, President Trump is directing the FDA to enhance the enforcement of reporting requirements regarding the sources of active pharmaceutical ingredients from foreign producers, and to contemplate publicly listing non-compliant facilities.

  • The Order tasks the Environmental Protection Agency (EPA) with hastening the establishment of facilities for the production of prescription drugs, active pharmaceutical ingredients, and other critical raw materials.
  • Moreover, the Order ensures that federal agencies responsible for permitting domestic pharmaceutical manufacturing designate a single point of contact to coordinate permit applications, backed by interagency support from the White House Office of Management and Budget (OMB) to streamline the process.

SPURRING ECONOMIC GROWTH AND ENHANCING NATIONAL SECURITY THROUGH PERMITTING REFORM: President Trump is dismantling bureaucratic barriers to crucial domestic pharmaceutical manufacturing, aiming to usher in a new era of prosperity by guaranteeing access to essential medications for Americans.

  • Significant challenges persist in creating a resilient, affordable domestic pharmaceutical supply chain for American patients.

    • New construction projects must navigate an intricate web of Federal, State, and local regulations, from building codes to zoning laws and environmental standards, which collectively deter investment in large-scale manufacturing initiatives.

  • Estimates indicate that the establishment of new manufacturing capacity for pharmaceuticals and essential inputs could take anywhere from five to ten years—an unacceptable delay from a national-security perspective.
  • This Executive Order aims to shorten the timelines for setting up domestic pharmaceutical manufacturing sites by minimizing regulatory obstacles to construction.

FULFILLING PROMISES TO PRIORITIZE AMERICAN INTERESTS: President Trump is making good on his commitment to prioritize American manufacturing by ensuring the FDA favors domestic facilities over foreign counterparts.

  • President Trump stated: “We don’t want to be buying our pharmaceuticals from other countries because if we’re in a war, we’re in a problem; we want to be able to make our own.”
  • He further emphasized, “As we invest in the future, we will permanently bring our medical supply chains back home. We will produce our medical supplies, pharmaceuticals, and treatments right here in the United States.”
  • This Executive Order builds upon actions taken during President Trump’s first term to reshore the production of essential medicines and reduce reliance on foreign suppliers.

See also  'White Lotus' Remains Ad-Free on HBO, But Lures Sponsors to Max
TAGGED:ActionsannouncesBarriersDomesticDonaldHousemanufacturingPharmaceuticalpresidentReduceRegulatoryTrumpWhite
Share This Article
Twitter Email Copy Link Print
Previous Article The Best Brooches at the 2025 Met Gala The Best Brooches at the 2025 Met Gala
Next Article NASA Reveals ‘Higher Than Expected’ Sea Level Rise in 2024 : ScienceAlert NASA Reveals ‘Higher Than Expected’ Sea Level Rise in 2024 : ScienceAlert
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Oklahoma Moves to Require Schools to Ask Students’ Immigration Status

Oklahoma education leaders recently made a controversial decision to require proof of citizenship or immigration…

January 28, 2025

Emily Simpson on Alexis, Shannon’s DUI, Background Checks

What was it like navigating the drama surrounding Shannon Beador this season? It was definitely…

October 31, 2024

What it means and how to achieve it

Financial freedom is a goal that many people strive for throughout their lives. It's the…

June 24, 2025

Matthew Courtney, Downtown Artist Who Platformed Others, Dies at 66

Street artist Matthew Courtney, a pivotal figure in the Lower East Side arts community, passed…

May 8, 2025

The startups rolling out of Europe’s early-stage micromobility scene

Micromobility, the industry focused on providing small, sustainable transportation solutions in urban areas, has been…

June 22, 2025

You Might Also Like

President Donald J. Trump Announces Actions to Reduce Regulatory Barriers to Domestic Pharmaceutical Manufacturing – The White House
The White House

ICE Arrests Surge Nationwide – The White House

July 22, 2025
House oversight panel scrutinizes organ transplant system
Health and Wellness

House oversight panel scrutinizes organ transplant system

July 22, 2025
JUST IN: Trump Announces  MILLION Settlement with CBS Over Fraudulent Kamala Harris Interview – “All Other Mainstream Media Liars, are ON NOTICE” |
Politics

JUST IN: Trump Announces $16 MILLION Settlement with CBS Over Fraudulent Kamala Harris Interview – “All Other Mainstream Media Liars, are ON NOTICE” |

July 22, 2025
Met Museum Announces Highest Attendance Numbers Since 2019 
Culture and Arts

Met Museum Announces Highest Attendance Numbers Since 2019 

July 22, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?